REIT - Office
Compare Stocks
2 / 10Stock Comparison
ELME vs NHI
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Healthcare Facilities
ELME vs NHI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | REIT - Office | REIT - Healthcare Facilities |
| Market Cap | $192M | $3.54B |
| Revenue (TTM) | $0.00 | $402M |
| Net Income (TTM) | $-154M | $148M |
| Gross Margin | — | 52.4% |
| Operating Margin | — | 35.6% |
| Forward P/E | — | 21.6x |
| Total Debt | $520M | $1.16B |
| Cash & Equiv. | $1.33B | $20M |
ELME vs NHI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Elme Communities (ELME) | 100 | 9.8 | -90.2% |
| National Health Inv… (NHI) | 100 | 131.7 | +31.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ELME vs NHI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ELME is the clearest fit if your priority is income & stability and defensive.
- Dividend streak 0 yrs, beta 0.47, yield 33.5%
- Beta 0.47, yield 33.5%, current ratio 1.02x
- Better valuation composite
NHI carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 12.9%, EPS growth -3.5%, 3Y rev CAGR 10.8%
- 59.2% 10Y total return vs ELME's -10.0%
- Lower volatility, beta -0.08, Low D/E 75.6%, current ratio 2.48x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 12.9% FFO/revenue growth vs ELME's -100.0% | |
| Value | Better valuation composite | |
| Quality / Margins | 36.8% margin vs ELME's -1.5% | |
| Stability / Safety | Lower D/E ratio (75.6% vs 217.7%) | |
| Dividends | 33.5% yield, vs NHI's 4.9% | |
| Momentum (1Y) | +8.2% vs NHI's +0.9% | |
| Efficiency (ROA) | 5.3% ROA vs ELME's -8.3%, ROIC 5.6% vs -15.3% |
ELME vs NHI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
ELME vs NHI — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
NHI leads this category, winning 2 of 2 comparable metrics.
Income & Cash Flow (Last 12 Months)
NHI and ELME operate at a comparable scale, with $402M and $0 in trailing revenue. On growth, NHI holds the edge at +28.9% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $0 | $402M |
| EBITDAEarnings before interest/tax | -$44M | $229M |
| Net IncomeAfter-tax profit | -$154M | $148M |
| Free Cash FlowCash after capex | $62M | $229M |
| Gross MarginGross profit ÷ Revenue | — | +52.4% |
| Operating MarginEBIT ÷ Revenue | — | +35.6% |
| Net MarginNet income ÷ Revenue | — | +36.8% |
| FCF MarginFCF ÷ Revenue | — | +56.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | -4.0% | +28.9% |
| EPS Growth (YoY)Latest quarter vs prior year | -6.6% | +10.8% |
Valuation Metrics
ELME leads this category, winning 3 of 3 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $192M | $3.5B |
| Enterprise ValueMkt cap + debt − cash | -$620M | $4.7B |
| Trailing P/EPrice ÷ TTM EPS | -1.23x | 24.20x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 21.58x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | 16.82x |
| Price / SalesMarket cap ÷ Revenue | — | 9.36x |
| Price / BookPrice ÷ Book value/share | 0.80x | 2.23x |
| Price / FCFMarket cap ÷ FCF | 3.08x | 16.08x |
Profitability & Efficiency
NHI leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
NHI delivers a 9.8% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $-19 for ELME. NHI carries lower financial leverage with a 0.76x debt-to-equity ratio, signaling a more conservative balance sheet compared to ELME's 2.18x. On the Piotroski fundamental quality scale (0–9), NHI scores 6/9 vs ELME's 4/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -18.9% | +9.8% |
| ROA (TTM)Return on assets | -8.3% | +5.3% |
| ROICReturn on invested capital | -15.3% | +5.6% |
| ROCEReturn on capital employed | -10.1% | +8.0% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 6 |
| Debt / EquityFinancial leverage | 2.18x | 0.76x |
| Net DebtTotal debt minus cash | -$812M | $1.1B |
| Cash & Equiv.Liquid assets | $1.3B | $20M |
| Total DebtShort + long-term debt | $520M | $1.2B |
| Interest CoverageEBIT ÷ Interest expense | -3.82x | 3.45x |
Total Returns (Dividends Reinvested)
NHI leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in NHI five years ago would be worth $12,999 today (with dividends reinvested), compared to $8,752 for ELME. Over the past 12 months, ELME leads with a +8.2% total return vs NHI's +0.9%. The 3-year compound annual growth rate (CAGR) favors NHI at 19.4% vs ELME's 4.0% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -3.9% | -3.7% |
| 1-Year ReturnPast 12 months | +8.2% | +0.9% |
| 3-Year ReturnCumulative with dividends | +12.4% | +70.3% |
| 5-Year ReturnCumulative with dividends | -12.5% | +30.0% |
| 10-Year ReturnCumulative with dividends | -10.0% | +59.2% |
| CAGR (3Y)Annualised 3-year return | +4.0% | +19.4% |
Risk & Volatility
NHI leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
NHI is the less volatile stock with a -0.08 beta — it tends to amplify market swings less than ELME's 0.47 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NHI currently trades 80.4% from its 52-week high vs ELME's 12.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.47x | -0.08x |
| 52-Week HighHighest price in past year | $17.68 | $90.94 |
| 52-Week LowLowest price in past year | $1.98 | $68.80 |
| % of 52W HighCurrent price vs 52-week peak | +12.2% | +80.4% |
| RSI (14)Momentum oscillator 0–100 | 52.2 | 29.0 |
| Avg Volume (50D)Average daily shares traded | 1.2M | 323K |
Analyst Outlook
Evenly matched — ELME and NHI each lead in 1 of 2 comparable metrics.
Analyst Outlook
Wall Street rates ELME as "Hold" and NHI as "Hold". Consensus price targets imply 779.6% upside for ELME (target: $19) vs 16.8% for NHI (target: $85). For income investors, ELME offers the higher dividend yield at 33.48% vs NHI's 4.93%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold |
| Price TargetConsensus 12-month target | $19.00 | $85.40 |
| # AnalystsCovering analysts | 8 | 18 |
| Dividend YieldAnnual dividend ÷ price | +33.5% | +4.9% |
| Dividend StreakConsecutive years of raises | 0 | 1 |
| Dividend / ShareAnnual DPS | $0.72 | $3.61 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
NHI leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). ELME leads in 1 (Valuation Metrics). 1 tied.
ELME vs NHI: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is ELME or NHI a better buy right now?
For growth investors, National Health Investors, Inc.
(NHI) is the stronger pick with 12. 9% revenue growth year-over-year, versus -100. 0% for Elme Communities (ELME). National Health Investors, Inc. (NHI) offers the better valuation at 24. 2x trailing P/E (21. 6x forward), making it the more compelling value choice. Analysts rate Elme Communities (ELME) a "Hold" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — ELME or NHI?
Over the past 5 years, National Health Investors, Inc.
(NHI) delivered a total return of +30. 0%, compared to -12. 5% for Elme Communities (ELME). Over 10 years, the gap is even starker: NHI returned +59. 2% versus ELME's -10. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — ELME or NHI?
By beta (market sensitivity over 5 years), National Health Investors, Inc.
(NHI) is the lower-risk stock at -0. 08β versus Elme Communities's 0. 47β — meaning ELME is approximately -657% more volatile than NHI relative to the S&P 500. On balance sheet safety, National Health Investors, Inc. (NHI) carries a lower debt/equity ratio of 76% versus 2% for Elme Communities — giving it more financial flexibility in a downturn.
04Which is growing faster — ELME or NHI?
By revenue growth (latest reported year), National Health Investors, Inc.
(NHI) is pulling ahead at 12. 9% versus -100. 0% for Elme Communities (ELME). On earnings-per-share growth, the picture is similar: National Health Investors, Inc. grew EPS -3. 5% year-over-year, compared to -1066. 7% for Elme Communities. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — ELME or NHI?
National Health Investors, Inc.
(NHI) is the more profitable company, earning 37. 6% net margin versus 0. 0% for Elme Communities — meaning it keeps 37. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NHI leads at 51. 5% versus 0. 0% for ELME. At the gross margin level — before operating expenses — NHI leads at 36. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is ELME or NHI more undervalued right now?
Analyst consensus price targets imply the most upside for ELME: 779.
6% to $19. 00.
07Which pays a better dividend — ELME or NHI?
All stocks in this comparison pay dividends.
Elme Communities (ELME) offers the highest yield at 33. 5%, versus 4. 9% for National Health Investors, Inc. (NHI).
08Is ELME or NHI better for a retirement portfolio?
For long-horizon retirement investors, National Health Investors, Inc.
(NHI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 08), 4. 9% yield). Both have compounded well over 10 years (NHI: +59. 2%, ELME: -10. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between ELME and NHI?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.